U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TILDRAKIZUMAB
DEW6X41BEK
US Approved Rx (2018)
First approved in 2018
General
Names
10
Classification
3
Identifiers
16
Subunits
4
Related Substances
1
TILDRAKIZUMAB
DEW6X41BEK
US Approved Rx (2018)
First approved in 2018
General
Approval Year
2018
425
Names
10
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TILDRAKIZUMAB
Official Name
English
TILDRAKIZUMAB, LICENSE HOLDER UNSPECIFIED
Preferred Name
English
TILDRAKIZUMAB [JAN]
Common Name
English
MK-3222
Code
English
Tildrakizumab [WHO-DD]
Common Name
English
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Established Pharmacologic Class
Established Pharmacologic Class
[EPC]
Interleukin-23 Antagonist
[EPC]
NDF-RT
N0000192799
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Interleukin inhibitors
ATC
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
Interleukin inhibitors
tildrakizumab
WHO-ATC
L04AC17
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
16
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
ChEMBL
CHEMBL2108681
PRIMARY
USAN
ZZ-43
PRIMARY
LACTMED
Tildrakizumab
PRIMARY
CAS
1326244-10-3
PRIMARY
DRUG CENTRAL
5281
PRIMARY
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
DEW6X41BEK
TILDRAKIZUMAB